Published 23 December 2002. doi:10.1083/jcb.200207070
© The Rockefeller University Press,
0021-9525/2002/12/1061 $5.00
The Journal of Cell Biology, Volume 159, Number 6, 1061-1070
Regulation of Rac1 activation by the low density lipoprotein receptorrelated protein
Zhong Ma1,
Keena S. Thomas1,
Donna J. Webb3,
Radim Moravec2,
Ana Maria Salicioni1,
Wendy M. Mars4 and
Steven L. Gonias1,2
1 Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA 22908
2 Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908
3 Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA 22908
4 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
Address correspondence to Steven L. Gonias, Dept. of Pathology, University of Virginia School of Medicine, Box 800214, Charlottesville, VA 22908. Tel.: (434) 924-9192. Fax: (434) 982-0283. E-mail: slg2t{at}virginia.edu
The low density lipoprotein receptorrelated protein (LRP-1) binds and mediates the endocytosis of multiple ligands, transports the urokinase-type plasminogen activator receptor (uPAR) and other membrane proteins into endosomes, and binds intracellular adaptor proteins involved in cell signaling. In this paper, we show that in murine embryonic fibroblasts (MEFs) and L929 cells, LRP-1 functions as a major regulator of Rac1 activation, and that this activity depends on uPAR. LRP-1deficient MEFs demonstrated increased Rac1 activation compared with LRP-1expressing MEFs, and this property was reversed by expressing the VLDL receptor, a member of the same gene family as LRP-1, with overlapping ligand-binding specificity. Neutralizing the activity of LRP-1 with receptor-associated protein (RAP) increased Rac1 activation and cell migration in MEFs and L929 cells. The same parameters were unaffected by RAP in uPAR-/- MEFs, prepared from uPAR gene knockout embryos, and in uPAR-deficient LM-TK- cells. Untreated uPAR+/+ MEFs demonstrated substantially increased Rac1 activation compared with uPAR-/- MEFs. In addition to Rac1, LRP-1 suppressed activation of extracellular signalregulated kinase (ERK) in MEFs; however, it was Rac1 (and not ERK) that was responsible for the effects of LRP-1 on MEF migration. Thus, LRP-1 regulates two signaling proteins in the same cell (Rac1 and ERK), both of which may impact on cell migration. In uPAR-negative cells, LRP-1 neutralization does not affect Rac1 activation, and other mechanisms by which LRP-1 may regulate cell migration are not unmasked.
Key Words: urokinase-type plasminogen activator; uPAR; extracellular signalregulated kinase; cell migration; VLDL receptor

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Smith, H. W., Marra, P., Marshall, C. J.
(2008). uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. JCB
182: 777-790
[Abstract]
[Full Text]
-
Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., Strickland, D. K.
(2008). LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies. Physiol. Rev.
88: 887-918
[Abstract]
[Full Text]
-
Gaultier, A., Arandjelovic, S., Niessen, S., Overton, C. D., Linton, M. F., Fazio, S., Campana, W. M., Cravatt, B. F. III, Gonias, S. L.
(2008). Regulation of tumor necrosis factor receptor-1 and the IKK-NF-{kappa}B pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood
111: 5316-5325
[Abstract]
[Full Text]
-
Dedieu, S., Langlois, B., Devy, J., Sid, B., Henriet, P., Sartelet, H., Bellon, G., Emonard, H., Martiny, L.
(2008). LRP-1 Silencing Prevents Malignant Cell Invasion despite Increased Pericellular Proteolytic Activities. Mol. Cell. Biol.
28: 2980-2995
[Abstract]
[Full Text]
-
Montel, V., Gaultier, A., Lester, R. D., Campana, W. M., Gonias, S. L.
(2007). The Low-Density Lipoprotein Receptor Related Protein Regulates Cancer Cell Survival and Metastasis Development. Cancer Res.
67: 9817-9824
[Abstract]
[Full Text]
-
Lester, R. D., Jo, M., Montel, V., Takimoto, S., Gonias, S. L.
(2007). uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells. JCB
178: 425-436
[Abstract]
[Full Text]
-
Camino-Lopez, S., Llorente-Cortes, V., Sendra, J., Badimon, L.
(2007). Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells. Cardiovasc Res
73: 208-216
[Abstract]
[Full Text]
-
Maquerlot, F., Galiacy, S., Malo, M., Guignabert, C., Lawrence, D. A., d'Ortho, M.-P., Barlovatz-Meimon, G.
(2006). Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing. Am. J. Pathol.
169: 1624-1632
[Abstract]
[Full Text]
-
Bujo, H., Saito, Y.
(2006). Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family. Arterioscler. Thromb. Vasc. Bio.
26: 1246-1252
[Abstract]
[Full Text]
-
Monaghan-Benson, E., McKeown-Longo, P. J.
(2006). Urokinase-type Plasminogen Activator Receptor Regulates a Novel Pathway of Fibronectin Matrix Assembly Requiring Src-dependent Transactivation of Epidermal Growth Factor Receptor. J. Biol. Chem.
281: 9450-9459
[Abstract]
[Full Text]
-
Gaultier, A., Salicioni, A. M., Arandjelovic, S., Gonias, S. L.
(2006). Regulation of the Composition of the Extracellular Matrix by Low Density Lipoprotein Receptor-related Protein-1: ACTIVITIES BASED ON REGULATION OF mRNA EXPRESSION. J. Biol. Chem.
281: 7332-7340
[Abstract]
[Full Text]
-
Bauer, T. W., Liu, W., Fan, F., Camp, E. R., Yang, A., Somcio, R. J., Bucana, C. D., Callahan, J., Parry, G. C., Evans, D. B., Boyd, D. D., Mazar, A. P., Ellis, L. M.
(2005). Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice. Cancer Res.
65: 7775-7781
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., Marozkina, N., Amin, T. J., Silva, C. M., Parsons, S. J., Gonias, S. L.
(2005). Dynamic Assembly of the Urokinase-type Plasminogen Activator Signaling Receptor Complex Determines the Mitogenic Activity of Urokinase-type Plasminogen Activator. J. Biol. Chem.
280: 17449-17457
[Abstract]
[Full Text]
-
Tanaga, K., Bujo, H., Zhu, Y., Kanaki, T., Hirayama, S., Takahashi, K., Inoue, M., Mikami, K., Schneider, W. J., Saito, Y.
(2004). LRP1B Attenuates the Migration of Smooth Muscle Cells by Reducing Membrane Localization of Urokinase and PDGF Receptors. Arterioscler. Thromb. Vasc. Bio.
24: 1422-1428
[Abstract]
[Full Text]
-
Zhu, Y., Bujo, H., Yamazaki, H., Ohwaki, K., Jiang, M., Hirayama, S., Kanaki, T., Shibasaki, M., Takahashi, K., Schneider, W. J., Saito, Y.
(2004). LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell Migration. Circ. Res.
94: 752-758
[Abstract]
[Full Text]
-
Salicioni, A. M., Gaultier, A., Brownlee, C., Cheezum, M. K., Gonias, S. L.
(2004). Low Density Lipoprotein Receptor-related Protein-1 Promotes {beta}1 Integrin Maturation and Transport to the Cell Surface. J. Biol. Chem.
279: 10005-10012
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., Wu, L., Gonias, S. L.
(2003). Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling. J. Biol. Chem.
278: 46692-46698
[Abstract]
[Full Text]
-
Moore, P. L., Ong, S., Harrison, T. J.
(2003). Squamous Cell Carcinoma Antigen 1-mediated Binding of Hepatitis B Virus to Hepatocytes Does Not Involve the Hepatic Serpin Clearance System. J. Biol. Chem.
278: 46709-46717
[Abstract]
[Full Text]
-
Orr, A. W., Elzie, C. A., Kucik, D. F., Murphy-Ullrich, J. E.
(2003). Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell Sci.
116: 2917-2927
[Abstract]
[Full Text]